PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-11-19

Date Title Company
19-Nov-2024 Nouscom Completes Patient Enrollment of Randomized Phase 2 Study Evaluating NOUS-209, an Off-the-Shelf Neoantigen Immunotherapy, in dMMR/MSI Metastatic Colorectal Cancer Nouscom
19-Nov-2024 Scintil Photonics names Matt Crowley as CEO, founder Sylvie Menezo will continue heading technology developments and customer partnerships Andrew Lloyd Associates
19-Nov-2024 PLL Therapeutics obtains authorization to start phase I/II trial in Australia for patients with Amyotrophic Lateral Sclerosis (ALS)  Andrew Lloyd Associates
19-Nov-2024 LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab AccessWire
19-Nov-2024 New Partnership: Bioz Helps DNA Polymerase Technology to Boost Research Visibility Through Interactive Citation Badges AccessWire
19-Nov-2024 Thermosome Presents Encouraging Initial Clinical Data from Phase I Trial of Lead Compound THE001 Thermosome
19-Nov-2024 M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets M1 Kliniken AG
19-Nov-2024 Kuros Biosciences Expands into Extremities Markets AccessWire
19-Nov-2024 Siegfried opens new global R&D Center for Drug Substances in Evionnaz Siegfried AG
19-Nov-2024 Kuros Biosciences Expands into Extremities Markets Kuros Biosciences AG
19-Nov-2024 Formycon invites to earnings call on the nine-month results 2024 and announces participation in international investor conferences Formycon AG